The global Osteoporosis Drugs Market is growing steadily as the aging population, sedentary lifestyles, and rising fracture risk increase demand for effective bone health treatments. Osteoporosis drugs help prevent bone loss, reduce fracture risk, and improve quality of life for patients with fragile bones.

The global osteoporosis drugs market size was valued at USD 16.43 billion in 2025 and is projected to grow from USD 17.17 billion in 2026 to USD 24.48 billion by 2034, registering a CAGR of 4.53% during the forecast period (2026–2034).

Market Size (2025): USD 16.43 Billion
Market Size (2026): USD 17.17 Billion
CAGR (2026–2034): 4.53%
Forecast Year: 2034
Projected Market Size (2034): USD 24.48 Billion
Dominant Region: North America
Fastest Growing Region: Europe
Click to Read the Complete Insights & Report:https://straitsresearch.com/re....port/osteoporosis-dr